400
Views
16
CrossRef citations to date
0
Altmetric
Original Article

RETRACTED ARTICLE: Maternal and fetal outcome in women with antiphospholipid syndrome: a three-year observational study

, &
Pages 4015-4019 | Received 16 Jan 2016, Accepted 05 Feb 2016, Published online: 03 Mar 2016
 

Abstract

We, the Editors and Publisher of The Journal of Maternal-Fetal and Neonatal Medicine are issuing an expression of concern for the following article:

Mohamed Rezk, Ragab Dawood & Hassan Badr (2016) Maternal and fetal outcome in women with antiphospholipid syndrome: a three-year observational study, The Journal of Maternal-Fetal & Neonatal Medicine, 29:24, 4015-4019, DOI: 10.3109/14767058.2016.1152254

After publication of this article, questions about the scientific integrity of the article content were brought to the Publisher and Editor’s attention. When approached for an explanation, the authors have not been able to provide responses or sufficient supporting information within the requested timeframe. Therefore, as we continue to work through the issues raised, we advise readers to interpret the information presented in the article with due caution.

The authors have been notified about this Expression of Concern.

View retraction statement:
RETRACTED ARTICLE: Maternal and fetal outcome in women with antiphospholipid syndrome: a three-year observational study
View addendum:
Expression of Concern

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.